Clinical trial
The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory…
NCT00314561 · Korea University Anam Hospital, Other · Completed
Key facts
| NCT number | NCT00314561 |
|---|---|
| Title | The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome |
| Official title | The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome: A Prospective, Randomized, Open-label, Crossover Trial |
| Lead sponsor | Korea University Anam Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Metabolic Syndrome |
| Intervention type | Drug |
| Interventions | Pioglitazone, Rosiglitazone |
| Enrollment | 40 |
| Start date | May 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Apr 14, 2006 |
| Last update posted | Jul 1, 2011 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: